Burning Rock Biotech Limited (BNR)
USD 2.95
(0.34%)
USD 2.95
(0.34%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | -653.68 Million CNY | 32.69% |
| 2022 | -971.23 Million CNY | -21.91% |
| 2021 | -796.69 Million CNY | -113.19% |
| 2020 | -373.7 Million CNY | -122.0% |
| 2019 | -168.33 Million CNY | 5.16% |
| 2018 | -177.49 Million CNY | -35.21% |
| 2017 | -131.27 Million CNY | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q1 | -121.54 Million CNY | 25.07% |
| 2024 Q2 | -108.03 Million CNY | 11.12% |
| 2023 Q3 | -174.98 Million CNY | -33.33% |
| 2023 Q1 | -185.25 Million CNY | 14.32% |
| 2023 Q2 | -131.24 Million CNY | 29.16% |
| 2023 FY | -653.68 Million CNY | 32.69% |
| 2023 Q4 | -162.21 Million CNY | 7.3% |
| 2022 Q4 | -216.22 Million CNY | 4.46% |
| 2022 Q3 | -226.3 Million CNY | 13.67% |
| 2022 Q2 | -262.13 Million CNY | -1.62% |
| 2022 FY | -971.23 Million CNY | -21.91% |
| 2022 Q1 | -257.96 Million CNY | -2.72% |
| 2021 FY | -796.69 Million CNY | -113.19% |
| 2021 Q4 | -251.14 Million CNY | -47.32% |
| 2021 Q3 | -170.47 Million CNY | 16.3% |
| 2021 Q2 | -203.66 Million CNY | -18.82% |
| 2021 Q1 | -171.41 Million CNY | -9.54% |
| 2020 Q2 | -71.05 Million CNY | -35.16% |
| 2020 FY | -373.7 Million CNY | -122.0% |
| 2020 Q1 | -52.57 Million CNY | 44.72% |
| 2020 Q4 | -156.47 Million CNY | -23.09% |
| 2020 Q3 | -127.13 Million CNY | -78.92% |
| 2019 Q2 | -26.03 Million CNY | -64.07% |
| 2019 Q4 | -95.09 Million CNY | -195.63% |
| 2019 Q3 | -32.16 Million CNY | -23.58% |
| 2019 Q1 | -15.86 Million CNY | 76.71% |
| 2019 FY | -168.33 Million CNY | 5.16% |
| 2018 FY | -177.49 Million CNY | -35.21% |
| 2018 Q4 | -68.12 Million CNY | 0.0% |
| 2017 FY | -131.27 Million CNY | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Aclaris Therapeutics, Inc. | -88.48 Million USD | -638.79% |
| Applied DNA Sciences, Inc. | -9.94 Million USD | -6471.681% |
| Aspira Women's Health Inc. | -16.69 Million USD | -3816.651% |
| Biodesix, Inc. | -52.14 Million USD | -1153.575% |
| BioNexus Gene Lab Corp. | -2.62 Million USD | -24764.143% |
| bioAffinity Technologies, Inc. | -7.93 Million USD | -8135.959% |
| bioAffinity Technologies, Inc. | -7.93 Million USD | -8135.959% |
| Bionano Genomics, Inc. | -232.49 Million USD | -181.165% |
| CareDx, Inc | -190.28 Million USD | -243.533% |
| Check-Cap Ltd. | -17.56 Million USD | -3620.907% |
| Castle Biosciences, Inc. | -57.46 Million USD | -1037.523% |
| DarioHealth Corp. | -59.42 Million USD | -999.987% |
| Exact Sciences Corporation | -204.14 Million USD | -220.202% |
| Fulgent Genetics, Inc. | -167.82 Million USD | -289.506% |
| Guardant Health, Inc. | -479.44 Million USD | -36.342% |
| ICON Public Limited Company | 612.33 Million USD | 206.753% |
| IDEXX Laboratories, Inc. | 845.04 Million USD | 177.356% |
| Illumina, Inc. | -1.16 Billion USD | 43.696% |
| Intelligent Bio Solutions Inc. | -10.15 Million USD | -6336.0% |
| iSpecimen Inc. | -11.09 Million USD | -5789.362% |
| Standard BioTools Inc. | -74.65 Million USD | -775.601% |
| MDxHealth SA | -43.1 Million USD | -1416.68% |
| 23andMe Holding Co. | -666.7 Million USD | 1.952% |
| Medpace Holdings, Inc. | 282.81 Million USD | 331.141% |
| Myriad Genetics, Inc. | -112 Million USD | -483.651% |
| Mainz Biomed B.V. | -26.29 Million USD | -2385.913% |
| ENDRA Life Sciences Inc. | -10.06 Million USD | -6397.741% |
| NeoGenomics, Inc. | -87.96 Million USD | -643.099% |
| Neogen Corporation | -9.42 Million USD | -6838.637% |
| Inotiv, Inc. | -105.14 Million USD | -521.732% |
| Natera, Inc. | -434.8 Million USD | -50.342% |
| OpGen, Inc. | -32.66 Million USD | -1900.975% |
| OPKO Health, Inc. | -188.86 Million USD | -246.118% |
| Psychemedics Corporation | -4.15 Million USD | -15636.375% |
| Prenetics Global Limited | -62.72 Million USD | -942.169% |
| Prenetics Global Limited | -62.72 Million USD | -942.169% |
| Precipio, Inc. | -5.85 Million USD | -11068.444% |
| Personalis, Inc. | -108.29 Million USD | -503.613% |
| RadNet, Inc. | 3.04 Million USD | 21574.671% |
| Sera Prognostics, Inc. | -36.24 Million USD | -1703.678% |
| Sotera Health Company | 51.37 Million USD | 1372.363% |
| Neuronetics, Inc. | -30.18 Million USD | -2065.322% |
| Star Equity Holdings, Inc. | -1.54 Million USD | -42127.972% |
| Star Equity Holdings, Inc. | -1.54 Million USD | -42127.972% |
| Trinity Biotech plc | -24.01 Million USD | -2621.663% |
| T2 Biosystems, Inc. | -50.07 Million USD | -1205.368% |
| Twist Bioscience Corporation | -208.72 Million USD | -213.18% |
| Exagen Inc. | -23.68 Million USD | -2659.462% |